NeurANO Bioscience is working on a project supported by a $2.5 million grant from the National Institute of Drug Abuse

NeurANO Bioscience is working on a NIDA-supported project titled “Evaluation of the therapeutic potential of exclusive antagonists of extrasynaptic NMDA receptors for the treatment of opioid use disorder.” In this project, we are determining how our nanotherapeutics perform at different stages of opioid use disorder (OUD), including drug acquisition, withdrawal, and relapse.